共 50 条
- [1] Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 72 - 77
- [2] Predicting Outcomes after Salvage Reirradiation of Recurrent Head and Neck Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S441 - S441
- [3] Salvage Stereotactic Reirradiation With or Without Cetuximab for Locally Recurrent Head-and-Neck Cancer: A Feasibility Study [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (01): : 203 - 209
- [5] Prognostic factors of reirradiation for recurrent head and neck cancer [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 408 - 413
- [6] Salvage Stereotactic Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S429 - S429
- [7] Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer [J]. Annals of Surgical Oncology, 2016, 23 : 850 - 857
- [9] Reirradiation for recurrent head and neck cancer [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1177 - 1189
- [10] REIRRADIATION FOR RECURRENT HEAD AND NECK CANCER [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S328 - S329